Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸
@FilipaLynce
Followers
2K
Following
5K
Media
47
Statuses
626
Breast Oncologist @ Dana-Farber Cancer Institute. Director, Dana Farber IBC Program. DFCI Center for BRCA and related genes. Alliance EO. Tweets are my own.
Boston, MA
Joined November 2014
So grateful for this amazing team of patients, advocates and colleagues who work every day to improve the lives of patients diagnosed with IBC! Team IBC at Jimmy Fund Walk 2023 @IBC_DanaFarber @DFCI_BreastOnc @TalkIBC
5
6
33
RT @DFCI_BreastOnc: Dr Hal Burstein (@HaroldBurstein) moderated the Early #BreastCancer Tumor Board at the #HarvardBreastCancerCourse, wher….
0
6
0
RT @DFCI_BreastOnc: Dr. Filipa Lynce (@FilipaLynce) discussed #InflammatoryBreastCancer on Day 1 of the #HarvardBreastCancerCourse, coverin….
0
6
0
RT @DFCI_BreastOnc: The #HarvardBreastCancerCourse starts on Thursday!.📅July 17 & 18.📍Westin Copley Place, Boston, MA.The @harvardmed #Brea….
0
11
0
RT @DFCI_BreastOnc: Check out this recent paper on #InflammatoryBreastCancer, it examines the clinicogenomic characterization of #IBC. 👉h….
0
20
0
RT @DanaFarber: We’re proud to be included in @Newsweek’s America’s Greatest Workplaces by State 2025 list. This recognition reflects our o….
0
6
0
RT @DanaFarber: A new study led by Dipanjan Chowdhury, PhD, co-director of our Center for BRCA and Related Genes, uncovers why some cancers….
blog.dana-farber.org
Published: June 10, 2025Updated: June 11, 2025Written by: Beth DoughertyThere are two ways to fix things: the quick way and the careful one. In cancer, cells with BRCA1 mutations tend to choose the...
0
4
0
RT @JennGuerriero: We call ourselves the 3 musketeers. Today we scored 4% on an MPI R01 that will investigate targeting macrophages in Brca….
0
7
0
RT @tess_omeara: More fun with @OncLive @jhaveri_komal @KalinskyKevin discussing controversial topics in recent breast cancer trials. Heari….
0
3
0
RT @DFCI_BreastOnc: @SusanGKomen, the world’s leading #BreastCancer organization, is awarding $10.8 million in new research grants. “Komen’….
0
4
0
RT @DFCI_BreastOnc: Congratulations to Dr. Filipa Lynce (@FilipaLynce) recipient of the Women’s Health Collaboration Award.from the @MALife….
0
11
0
RT @drsarahsam: Study that went under the radar at ASCO. WBRT with hippocampal sparing and memantine versus SRS for 5-20 brain metastases….
0
52
0
RT @DrHBurstein: Registration open for virtual or in-person participation. A remarkable, thorough and efficient two days of breast cancer….
0
3
0
RT @DanaFarberBRCA: Last week we had the chance to celebrate Dr. Panos Konstantinopoulos on his promotion to Professor of Medicine at @harv….
0
2
0
RT @MedscapeLIVE: 🚨 If you're as serious about breast cancer care as @DrReshmaMahtani, @baik_alan, @antgiorda, @DrSGraff, @claudine_isaacs,….
0
8
0
RT @DFCI_BreastOnc: 👏Congratulations to @DanaFarber's Filipa Lynce, MD, FASCO (@FilipaLynce), recipient of the Advanced Clinical Research A….
0
10
0
RT @antgiorda: Dream team breast cancer researchers @DFCI_BreastOnc @DanaFarber pioneering advancement therapeutics for patients #bcsm @ASC….
0
12
0
RT @DFCI_BreastOnc: Happening Now #ASCO25 Poster Session 👉AXALAP: Phase Ib study of axatilimab in combination with olaparib in BRCA1/2 an….
0
4
0
RT @DFCI_BreastOnc: Happening Now! #ASCO25 Poster Session 👉Association between chemotherapy use and clinical outcomes in young BRCA carrier….
0
5
0